SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-21-000152
Filing Date
2021-09-02
Accepted
2021-09-02 19:20:24
Documents
1
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3371
  Complete submission text file 0000874015-21-000152.txt   4824
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
Cadoret-Manier Onaiza (Reporting) CIK: 0001799355 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 211234760